Start for free
Start for free
Polar Capital logo

Polar Capital

Europe, England, United Kingdom, London

Description

Polar Capital is an investment management company that offers a range of geographical and sector funds.

Investor Profile

Polar Capital has made 9 investments, with 2 in the past 12 months and 11% as lead.

Stage Focus

  • Post Ipo Equity (67%)
  • Series A (11%)
  • Series Unknown (11%)
  • Series D (11%)

Country Focus

  • United Kingdom (44%)
  • United States (33%)
  • France (22%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Banking
  • Financial Services
  • Fintech
  • Communities
  • Information Services
  • Training
  • Agriculture
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Polar Capital frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Abingworth
Abingworth
Europe, England, United Kingdom, London
Co-Investments: 2
Access Biotechnology
Access Biotechnology
North America, New York, United States, New York
Co-Investments: 2
Braidwell
Braidwell
North America, Connecticut, United States, Stamford
Co-Investments: 1
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Fairmount Funds Management
Fairmount Funds Management
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 2
Affinity Asset Advisors
Affinity Asset Advisors
North America, New York, United States, New York
Co-Investments: 1
CC
Commodore Capital
North America, New York, United States, New York
Co-Investments: 1
Boxer Capital
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 1

Which angels does Polar Capital often collaborate with?

ME
Martin Edwards
Europe, England, United Kingdom
Shared Deals: 1
CA
Chris Adelsbach
Europe, England, United Kingdom, London
Shared Deals: 1
JM
Jon Moulton
Europe, Guernsey
Shared Deals: 1
AU
Anders Ullman
Europe, Hallands Lan, Sweden, Kungsbacka
Shared Deals: 1
Mark W. Hahn
Mark W. Hahn
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1
VS
Vikas Sinha
North America, Massachusetts, United States, Boston
Shared Deals: 1
David Zaccardelli
David Zaccardelli
North America, United States
Shared Deals: 1
DE
David Ebsworth
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1
Terence James O'Neill
Shared Deals: 1

What are some of recent deals done by Polar Capital?

MedinCell

Jacou, Languedoc-Roussillon, France

MedinCell is an injectable slow-release drug specialist company.

Pharmaceutical
Post Ipo EquityFeb 19, 2025
Amount Raised: $44,831,521
Valneva

Saint-herblain, Pays de la Loire, France

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo EquitySep 13, 2024
Amount Raised: $67,833,293
Spyre Therapeutics

San Francisco, California, United States

Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.

BiotechnologyTherapeutics
Post Ipo EquityDec 7, 2023
Amount Raised: $180,000,000
New Level Work

San Francisco, California, United States

New Level Work provides leadership coaching and development programs for people leaders.

CommunitiesInformation ServicesTraining
Series ANov 18, 2022
Amount Raised: $16,000,000
Moneybox

London, England, United Kingdom

Moneybox is a mobile savings and investment app that offers a range of savings and investment products including Lifetime ISAs and Pensions.

BankingFinanceFinancial ServicesFinTech
Series DApr 4, 2022
Amount Raised: $45,894,778
Verona Pharma

London, England, United Kingdom

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityJul 17, 2020
Amount Raised: $200,000,000
Realm Therapeutics

Malvern, Pennsylvania, United States

Realm Tx is a clinical stage biopharmaceutical company passionately committed to leveraging its proprietary immunomodulatory technology

BiotechnologyPharmaceutical
Post Ipo EquitySep 22, 2017
Amount Raised: $26,000,000
Plant Impact

Harpenden, Hertford, United Kingdom

products manage a plant’s natural responses to stress factors to build its resilience.

AgricultureBiotechnologyFarming
Post Ipo EquityAug 23, 2017
Amount Raised: $5,100,000
Atom Bank

Durham, Durham, United Kingdom

Atom Bank is a mobile banking application that offers a range of personal and business banking products.

BankingFinancial ServicesFinTechMobile Apps
Series UnknownDec 4, 2014
Amount Raised: $39,178,075
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator